| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,432 |
23,015 |
$1.23M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,662 |
2,033 |
$156K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,252 |
2,908 |
$109K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,930 |
5,067 |
$106K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,406 |
1,761 |
$101K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,900 |
1,955 |
$83K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,858 |
1,524 |
$57K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
924 |
790 |
$22K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
232 |
218 |
$14K |
| 71046 |
Radiologic examination, chest; 2 views |
666 |
639 |
$10K |
| 73610 |
|
283 |
275 |
$7K |
| 73630 |
|
360 |
349 |
$7K |
| 81002 |
|
2,698 |
2,208 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
120 |
118 |
$7K |
| 73130 |
|
245 |
231 |
$4K |
| 90686 |
|
219 |
182 |
$4K |
| 81025 |
|
889 |
703 |
$3K |
| 87807 |
|
279 |
196 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
153 |
126 |
$2K |
| 99384 |
|
33 |
33 |
$2K |
| 69209 |
|
248 |
198 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
34 |
31 |
$1K |
| 99383 |
|
22 |
22 |
$1K |
| 73110 |
|
55 |
54 |
$1K |
| 12001 |
|
14 |
13 |
$841.20 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
441 |
314 |
$605.43 |
| 73564 |
|
13 |
13 |
$246.62 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
23 |
18 |
$225.63 |
| 73140 |
|
15 |
15 |
$216.99 |
| 81003 |
|
98 |
81 |
$203.17 |
| 82962 |
|
64 |
43 |
$119.60 |
| 86308 |
|
15 |
15 |
$72.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
14 |
$17.64 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
59 |
54 |
$6.69 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
79 |
69 |
$5.98 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
119 |
97 |
$0.00 |